Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
Open Access
- 1 February 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 134 (2) , 1003-1009
- https://doi.org/10.4049/jimmunol.134.2.1003
Abstract
The human glioblastoma cell line 308 constitutively secretes a soluble factor with biologic and biochemical characteristics of human monocyte-derived interleukin 1 (IL 1). The 308 cells also produce a 97,000 m.w. factor that inhibits the effects of IL 1 and interleukin 2 (IL 2) on T lymphocytes. By using sequential chromatography on Blue Affigel, hydroxyapatite, and Ultrogel AcA54, the inhibitory factor, termed glioblastoma-derived T cell suppressor factor (G-TsF), was separated from IL 1 and purified 2000-fold with respect to the protein present in the crude 308 cell supernatant. This G-TsF preparation was sensitive to tryptic proteolysis, showed a peak of pI 4.6 on isoelectric focusing, and when labeled with 125I, revealed six protein bands in the range of 30 to 100 kdaltons on SDS gel.This publication has 3 references indexed in Scilit:
- Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.The Journal of Immunology, 1984
- Binding sites for monoclonal antibodies and for mRNPs on SV40 large T‐antigen determined with a cleavage mapEuropean Journal of Biochemistry, 1983
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951